Free Trial

Kanabo Group (KNB) Competitors

Kanabo Group logo
GBX 0.22 0.00 (0.00%)
As of 05/15/2025

KNB vs. TLY, SPI, MGP, SBI, ODX, VRCI, BNR, EVG, GENF, and TRLS

Should you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Omega Diagnostics Group (ODX), Verici Dx (VRCI), Burning Rock Biotech (BNR), Evgen Pharma (EVG), Genflow Biosciences (GENF), and Trellus Health (TRLS). These companies are all part of the "medical" sector.

Kanabo Group vs.

Kanabo Group (LON:KNB) and Totally (LON:TLY) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, community ranking, earnings, analyst recommendations and dividends.

Kanabo Group has a beta of 3.04, meaning that its share price is 204% more volatile than the S&P 500. Comparatively, Totally has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.

Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users.

CompanyUnderperformOutperform
Kanabo GroupN/AN/A
TotallyOutperform Votes
131
72.38%
Underperform Votes
50
27.62%

Totally has a consensus target price of GBX 20, suggesting a potential upside of 1,500.00%. Given Totally's stronger consensus rating and higher possible upside, analysts clearly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Totally
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.29-0.17
Totally£133.05M0.02-£3.79M-£1.93-0.65

Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-717.63% -121.77% -20.89%
Totally -2.85%-11.01%-2.42%

In the previous week, Kanabo Group's average media sentiment score of 0.00 equaled Totally'saverage media sentiment score.

Company Overall Sentiment
Kanabo Group Neutral
Totally Neutral

3.8% of Kanabo Group shares are held by institutional investors. Comparatively, 51.3% of Totally shares are held by institutional investors. 37.0% of Kanabo Group shares are held by insiders. Comparatively, 13.3% of Totally shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Totally beats Kanabo Group on 10 of the 15 factors compared between the two stocks.

Get Kanabo Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KNB vs. The Competition

MetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£1.42M£1.70B£5.43B£2.68B
Dividend YieldN/A3.83%5.22%4.96%
P/E Ratio-0.177.3026.83135.15
Price / Sales1.2512.89394.87216,118.81
Price / Cash1.8212.5138.2528.03
Price / Book0.242.026.873.80
Net Income-£8.18M£58.65M£3.22B£5.88B
7 Day PerformanceN/A10.09%6.82%7.91%
1 Month Performance-6.25%85.99%13.72%29.42%
1 Year Performance-86.76%14.36%18.31%119.42%

Kanabo Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
N/AGBX 0.23
flat
N/AN/A£1.42M£1.14M-0.1720
TLY
Totally
N/AGBX 1.43
-1.7%
GBX 20
+1,303.5%
-83.3%£2.80M£133.05M-0.741,668
SPI
Spire Healthcare Group
1.9645 of 5 stars
GBX 198.80
+0.1%
GBX 300
+50.9%
-22.9%£798.32M£1.44B28.29420
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
VRCI
Verici Dx
N/AGBX 1.39
+1.1%
N/A-86.0%£4.22M£5.91M-0.8119Gap Down
BNR
Burning Rock Biotech
N/AN/AN/AN/A£3.77MN/A0.001,390Gap Down
High Trading Volume
EVG
Evgen Pharma
N/AN/AN/AN/A£3.42MN/A-80.0010
GENF
Genflow Biosciences
N/AGBX 1
+11.1%
N/A-57.6%£3.41M£-226,187.99-1.895Gap Up
TRLS
Trellus Health
N/AGBX 1.73
-6.5%
N/A+15.9%£3.34M£65,831.01-0.5031Gap Down

Related Companies and Tools


This page (LON:KNB) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners